Cargando…
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
Ewing sarcomas (ES) are highly malignant bone or soft tissue tumors. Genetically, ES are defined by balanced chromosomal EWS/ETS translocations, which give rise to chimeric proteins (EWS-ETS) that generate an oncogenic transcriptional program associated with altered epigenetic marks throughout the g...
Autores principales: | Hensel, Tim, Giorgi, Chiara, Schmidt, Oxana, Calzada-Wack, Julia, Neff, Frauke, Buch, Thorsten, Niggli, Felix K., Schäfer, Beat W., Burdach, Stefan, Richter, Günther H.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811472/ https://www.ncbi.nlm.nih.gov/pubmed/26623725 |
Ejemplares similares
-
The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma
por: von Heyking, Kristina, et al.
Publicado: (2016) -
Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma
por: H.S. Richter, Günther, et al.
Publicado: (2020) -
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma
por: von Heyking, Kristina, et al.
Publicado: (2017) -
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma
por: Loganathan, Sudan N., et al.
Publicado: (2016) -
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
por: Gierisch, Maria E., et al.
Publicado: (2019)